Compounds > bay h 4502

bay h 4502 and ketoconazole

bay h 4502 has been researched along with ketoconazole in 40 studies

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-19905 (12.50)18.7374
1990's8 (20.00)18.2507
2000's7 (17.50)29.6817
2010's17 (42.50)24.3611
2020's3 (7.50)2.80

Authors

AuthorsStudies
Apuzzo, G; Artico, M; Costi, R; Di Santo, R; Massa, S; Retico, A; Simonetti, G; Strippoli, V1
Artico, M; Botta, M; Ciacci, A; Corelli, F; Costi, R; Di Santo, R; Manetti, F; Massa, S; Tafi, A1
Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL1
Deising, HB; Serfling, A; Wohlrab, J1
Bartels, M; Hartmann, RW; Hu, Q; Jahn-Hoffmann, K; Lauterbach, T; Müller-Vieira, U; Negri, M; Olgen, S; Zhuang, Y1
Camoutsis, C; Cirić, A; Geronikaki, A; Glamoclija, J; Omar, K; Soković, M; Zoumpoulakis, P1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Camoutsis, C; Ciric, A; Geronikaki, A; Soković, M; Zervou, M; Zoumpoulakis, P1
Cirić, A; Geronikaki, A; Glamočlija, J; Liaras, K; Soković, M2
Camoutsis, Ch; Glamočlija, J; Pairas, G; Pitsas, A; Potamitis, C; Soković, M; Zoumpoulakis, P1
Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A1
Apostolidis, I; Ćirić, A; Gavalas, A; Geronikaki, A; Glamočlija, J; Hadjipavlou-Litina, D; Liaras, K; Soković, M1
Avery, VM; Sykes, ML1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bron, S; Chambon, M; Colau, D; Majjigapu, SR; Michielin, O; Pilotte, L; Röhrig, UF; Turcatti, G; Van den Eynde, BJ; Vogel, P; Zoete, V1
Apuzzo, G; Artico, M; Ortar, G; Silvestri, R; Simonetti, G; Stefancich, G1
Aoki, K; Hosaka, J; Uchida, K; Yamaguchi, H1
Panico, S; Porretta, GC; Scalzo, M; Simonetti, N; Villa, A1
Cauwenbergh, G1
Abruzzo, GK; Fromtling, RA; Giltinan, DM; Turnbull, TA1
Abbott, AB; Odds, FC; Webster, CE1
Qadripur, SA1
Espinel-Ingroff, A; Kerkering, TM; Shadomy, S1
Apuzzo, G; Artico, M; Pagnozzi, E; Retico, A; Silvestri, R; Simonetti, N; Stefancich, G1
Hegemann, L; Lahijani, KI; Toso, SM; Uitto, J; Webster, GF1
Inoue, I; Kitajima, Y; Osada, K; Seishima, M1
Ahmed, S; Keane, J1
Gee, BC1
Höltje, HD; Marian, C; Raub, S; Rupp, B1
Katoh, T1
Eichenfield, LF; Friedlander, SF1
Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K1
Geronikaki, A; Horishny, V; Ivanov, M; Kartsev, V; Kostic, M; Matiychuk, V; Papadopoulou, TA; Petrou, A; Pogodin, P; Poroikov, V; Sokovic, M; Vizirianakis, IS1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Emami, S; Keighobadi, M; Tavangar, P1
Camoutsis, C; Ciric, A; Eleftheriou, P; Fesatidou, M; Geronikaki, A; Haroun, M; Petrou, A; Sokovic, M; Tratrat, C; Zagaliotis, P1
Anthi, P; Athina, G; Boris, L; Marija, S; Marina, K; Marina, S; Oliver, R; Victor, K1
Ciric, A; Geronikaki, A; Glamoclija, J; Kartsev, V; Krysin, MY; Ledenyova, IV; Medvedeva, SM; Petrou, A; Shikhaliev, KS; Sokovic, M1
Ciric, A; Drumea, M; Geronikaki, A; Glamoclija, J; Kravtsov, V; Lupascu, L; Macaev, F; Petrou, A; Pogrebnoi, S; Smetanscaia, A; Sokovic, M; Stingaci, E; Uncu, L; Valica, V; Zveaghinteva, M1

Reviews

5 review(s) available for bay h 4502 and ketoconazole

ArticleYear
Approaches to protozoan drug discovery: phenotypic screening.
    Journal of medicinal chemistry, 2013, Oct-24, Volume: 56, Issue:20

    Topics: Drug Discovery; Humans; Molecular Structure; Neglected Diseases; Phenotype; Plasmodium falciparum; Protozoan Infections; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi

2013
Seborrhoeic dermatitis.
    Clinical evidence, 2004, Issue:12

    Topics: Dermatitis, Seborrheic; Humans; Imidazoles; Ketoconazole; Scalp Dermatoses; Selenium Compounds

2004
[Guidelines for diagnosis and treatment of mucocutaneous candidiasis].
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2009, Volume: 50, Issue:4

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Drug Administration Schedule; Humans; Imidazoles; Ketoconazole; Microscopy; Morpholines; Naphthalenes; Practice Guidelines as Topic; Terbinafine

2009
Pediatric Onychomycosis: The Emerging Role of Topical Therapy.
    Journal of drugs in dermatology : JDD, 2017, 02-01, Volume: 16, Issue:2

    Topics: Administration, Topical; Adult; Age Factors; Antifungal Agents; Child; Ciclopirox; Family; Humans; Imidazoles; Incidence; Ketoconazole; Lacquer; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Recurrence; Terbinafine; Tinea Pedis; Treatment Outcome

2017
An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy.
    European journal of medicinal chemistry, 2017, Jul-28, Volume: 135

    Topics: 14-alpha Demethylase Inhibitors; Antiprotozoal Agents; Azoles; Humans; Leishmania; Molecular Structure; Sterol 14-Demethylase

2017

Other Studies

35 other study(ies) available for bay h 4502 and ketoconazole

ArticleYear
Antifungal agents. 9. 3-Aryl-4-[alpha-(1H-imidazol-1-yl)arylmethyl]pyrroles: a new class of potent anti-Candida agents.
    Journal of medicinal chemistry, 1995, Oct-13, Volume: 38, Issue:21

    Topics: Adult; Animals; Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Microbial; Female; Humans; Hydrogen-Ion Concentration; Imidazoles; Male; Molecular Structure; Pyrroles; Rabbits; Structure-Activity Relationship

1995
Antifungal agents. 10. New derivatives of 1-[(aryl)[4-aryl-1H-pyrrol-3-yl]methyl]-1H-imidazole, synthesis, anti-candida activity, and quantitative structure-analysis relationship studies.
    Journal of medicinal chemistry, 2002, Jun-20, Volume: 45, Issue:13

    Topics: Antifungal Agents; Candida; Imidazoles; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Pyrroles; Quantitative Structure-Activity Relationship; Stereoisomerism

2002
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
    Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:3

    Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase

2007
Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Colletotrichum; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungi; Fungicides, Industrial; Humans; In Vitro Techniques; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Fluorescence; Nystatin; Plant Diseases; Skin; Triazoles

2007
Synthesis, biological evaluation, and molecular modeling studies of methylene imidazole substituted biaryls as inhibitors of human 17alpha-hydroxylase-17,20-lyase (CYP17)--part II: Core rigidification and influence of substituents at the methylene bridge.
    Bioorganic & medicinal chemistry, 2008, Aug-15, Volume: 16, Issue:16

    Topics: Animals; Binding Sites; Biphenyl Compounds; Enzyme Inhibitors; Humans; Imidazoles; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Male; Models, Molecular; Protein Structure, Secondary; Rats; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Steroid 17-alpha-Hydroxylase; Testosterone

2008
Novel 4-thiazolidinone derivatives as potential antifungal and antibacterial drugs.
    Bioorganic & medicinal chemistry, 2010, Jan-01, Volume: 18, Issue:1

    Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Isomerism; Microbial Sensitivity Tests; Structure-Activity Relationship; Thiazoles

2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Sulfonamide-1,2,4-thiadiazole derivatives as antifungal and antibacterial agents: synthesis, biological evaluation, lipophilicity, and conformational studies.
    Chemical & pharmaceutical bulletin, 2010, Volume: 58, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Fungi; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Structure-Activity Relationship; Sulfonamides; Thiadiazoles

2010
Thiazole-based chalcones as potent antimicrobial agents. Synthesis and biological evaluation.
    Bioorganic & medicinal chemistry, 2011, May-15, Volume: 19, Issue:10

    Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Chalcones; Fungi; Humans; Mycoses; Structure-Activity Relationship; Thiazoles

2011
Novel (E)-1-(4-methyl-2-(alkylamino)thiazol-5-yl)-3-arylprop-2-en-1-ones as potent antimicrobial agents.
    Bioorganic & medicinal chemistry, 2011, Dec-15, Volume: 19, Issue:24

    Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Structure-Activity Relationship; Thiazoles

2011
Synthesis of novel sulfonamide-1,2,4-triazoles, 1,3,4-thiadiazoles and 1,3,4-oxadiazoles, as potential antibacterial and antifungal agents. Biological evaluation and conformational analysis studies.
    Bioorganic & medicinal chemistry, 2012, Feb-15, Volume: 20, Issue:4

    Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Oxadiazoles; Thiadiazoles; Triazoles

2012
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bioorganic & medicinal chemistry letters, 2012, Dec-15, Volume: 22, Issue:24

    Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity

2012
Synthesis and biological evaluation of some 5-arylidene-2-(1,3-thiazol-2-ylimino)-1,3-thiazolidin-4-ones as dual anti-inflammatory/antimicrobial agents.
    Bioorganic & medicinal chemistry, 2013, Jan-15, Volume: 21, Issue:2

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Edema; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Thiazoles

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    European journal of medicinal chemistry, 2014, Sep-12, Volume: 84

    Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship

2014
Antibacterial and antifungal agents. XV. Synthesis and antifungal activity of structural analogues of bifonazole and ketoconazole.
    Archiv der Pharmazie, 1992, Volume: 325, Issue:11

    Topics: Antifungal Agents; Candida; Imidazoles; Ketoconazole; Microbial Sensitivity Tests

1992
[In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses].
    The Japanese journal of antibiotics, 1991, Volume: 44, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Dermatomycoses; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests

1991
Antimicrobial activity of a new derivative: N-(4-chlorobenzyl)-2-(1H-imidazol-1-ylmethyl)benzenamine.
    Drugs under experimental and clinical research, 1990, Volume: 16, Issue:4

    Topics: Aniline Compounds; Animals; Antifungal Agents; Candida; Candida albicans; Gram-Negative Bacteria; Imidazoles; Ketoconazole; Male; Miconazole; Microbial Sensitivity Tests; Rabbits

1990
New and prospective developments in antifungal drugs.
    Acta dermato-venereologica. Supplementum, 1986, Volume: 121

    Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles

1986
Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 20, Issue:1

    Topics: Animals; Antifungal Agents; Cell Survival; Centrifugation; Fluconazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Luminescent Measurements; Luminol; Mice; Mice, Inbred BALB C; Naphthalenes; Phagocytes; Rabbits; Rifampin; Spleen; Terbinafine; Triazoles

1987
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 14, Issue:2

    Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles

1984
[Antimycotic therapy. 2. Antimycotic chemotherapeutic agents: imidazole derivatives, tolciclate, haloprogin, ciclopiroxolamin].
    Fortschritte der Medizin, 1983, Mar-10, Volume: 101, Issue:9

    Topics: Antifungal Agents; Chemical Phenomena; Chemistry; Ciclopirox; Clotrimazole; Dermatomycoses; Econazole; Humans; Imidazoles; Ketoconazole; Miconazole; Phenyl Ethers; Piperazines; Pyridones; Thiocarbamates

1983
In-vitro studies with four new antifungal agents: BAY n 7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002.
    Sabouraudia, 1984, Volume: 22, Issue:1

    Topics: Antifungal Agents; Arthrodermataceae; Blastomyces; Candida; Coccidioides; Cryptococcus neoformans; Drug Evaluation, Preclinical; Histoplasma; Imidazoles; Ketoconazole; Miconazole; Morpholines; Sporothrix; Triazoles

1984
Antifungal agents. VI. In vitro antifungal activities of halobenzoyl esters of cis- and trans-[2-(1,1'-biphenyl-4-yl)-2-(1H-imidazol-1-ylmethyl)-1,3- dioxolan-4-yl]carbinols.
    Farmaco (Societa chimica italiana : 1989), 1993, Volume: 48, Issue:8

    Topics: Antifungal Agents; Biphenyl Compounds; Candida; Candida albicans; Dioxolanes; Imidazoles; Ketoconazole; Microbial Sensitivity Tests; Stereoisomerism

1993
Direct interaction of antifungal azole-derivatives with calmodulin: a possible mechanism for their therapeutic activity.
    The Journal of investigative dermatology, 1993, Volume: 100, Issue:3

    Topics: Antifungal Agents; Calmodulin; Clotrimazole; Drug Interactions; Econazole; Imidazoles; Ketoconazole; Kinetics; Miconazole; Phosphodiesterase Inhibitors; Polymyxin B

1993
Different effects of azole-antifungal agents on the regulation of intracellular calcium concentration of Trichophyton rubrum.
    Journal of dermatological science, 1996, Volume: 12, Issue:2

    Topics: Antifungal Agents; Azoles; Calcium; Chelating Agents; Edetic Acid; Humans; Imidazoles; Intracellular Membranes; Itraconazole; Ketoconazole; Osmolar Concentration; Trichophyton

1996
Modeling study of some inhibitors of 17,20-lyase, a component of the enzyme 17 alpha-hydroxylase/17,20-lyase: a novel approach.
    Biochemical and biophysical research communications, 1998, Dec-18, Volume: 253, Issue:2

    Topics: Binding Sites; Enzyme Inhibitors; Imidazoles; Ketoconazole; Models, Molecular; Protein Conformation; Steroid 17-alpha-Hydroxylase; Substrate Specificity

1998
Molecular design of two sterol 14alpha-demethylase homology models and their interactions with the azole antifungals ketoconazole and bifonazole.
    Journal of computer-aided molecular design, 2005, Volume: 19, Issue:3

    Topics: Amino Acid Sequence; Antifungal Agents; Binding Sites; Candida albicans; Computer-Aided Design; Conserved Sequence; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fungal Proteins; Humans; Imidazoles; Ketoconazole; Models, Molecular; Molecular Sequence Data; Mycobacterium tuberculosis; Oxidoreductases; Protein Conformation; Sequence Alignment; Sequence Homology, Amino Acid; Sterol 14-Demethylase

2005
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
    Medical mycology, 2020, Jul-01, Volume: 58, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole

2020
Synthesis, Biological Evaluation and Molecular Docking Studies of 5-Indolylmethylen-4-oxo-2-thioxothiazolidine Derivatives.
    Molecules (Basel, Switzerland), 2022, Feb-05, Volume: 27, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Escherichia coli; Fungi; Imidazoles; Ketoconazole; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Molecular Docking Simulation; Molecular Structure; Pseudomonas aeruginosa; Structure-Activity Relationship; Thiazolidines

2022
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
5-Adamantan thiadiazole-based thiazolidinones as antimicrobial agents. Design, synthesis, molecular docking and evaluation.
    Bioorganic & medicinal chemistry, 2018, 09-01, Volume: 26, Issue:16

    Topics: Adamantane; Anti-Infective Agents; Binding Sites; Drug Design; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Fungal Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Structure, Tertiary; Structure-Activity Relationship; Thiadiazoles; Thiazolidines

2018
Design, synthesis and antimicrobial activity of usnic acid derivatives.
    MedChemComm, 2018, May-01, Volume: 9, Issue:5

    Topics:

2018
Appendix A. dithioloquinolinethiones as new potential multitargeted antibacterial and antifungal agents: Synthesis, biological evaluation and molecular docking studies.
    European journal of medicinal chemistry, 2019, Aug-01, Volume: 175

    Topics: Anti-Bacterial Agents; Antifungal Agents; Carbon-13 Magnetic Resonance Spectroscopy; Chromatography, High Pressure Liquid; Drug Design; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Docking Simulation; Proton Magnetic Resonance Spectroscopy; Quinolines; Structure-Activity Relationship

2019
New vinyl-1,2,4-triazole derivatives as antimicrobial agents: Synthesis, biological evaluation and molecular docking studies.
    Bioorganic & medicinal chemistry letters, 2020, 09-01, Volume: 30, Issue:17

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Binding Sites; DNA Gyrase; Drug Design; Erwinia amylovora; Escherichia coli; Escherichia coli Proteins; Fungi; Microbial Sensitivity Tests; Molecular Docking Simulation; Nucleoside-Phosphate Kinase; Structure-Activity Relationship; Triazoles; Xanthomonas campestris

2020